Athersys Stem Cell Therapy Targets Top Cause of COVID-19 Deaths

Athersys says it is working as fast as it can to launch a pivotal trial of its MultiStem® adult-derived "off-the-shelf" stem cell product in acute respiratory distress syndrome (ARDS), after the clinical program received...

Novacyt Launches Two-Hour Coronavirus Test After FDA Approval

The French clinical diagnostics specialist Novacyt has announced FDA authorization for its fast and easily transportable test for the coronavirus disease COVID-19. The company is also rolling out the kit this week via manufacturing...

Moderna’s SARS-CoV-2 Vaccine’s Fast Track to Clinical Trials

The holy grail of the current pandemic—a vaccine for COVID-19—will not be available next month. It may not even be ready by next year. Regardless, the strides being made are happening at unprecedented speed....

Accurate and informative labeling of CBD products is a critical public health issue

Reviewed by Emily Henderson, B.Sc.Mar 25 2020 The need for accurate and informative labeling of hemp and hemp-derived cannabidiol (CBD) products is a critical public health issue. Despite CBD being a U.S. Food and Drug...

Advancing CAR T-cell therapy for treatment of solid tumors

Reviewed by Emily Henderson, B.Sc.Mar 25 2020 The full title of the research is "The study of the mechanisms of effectiveness of T-cells CAR-T towards solid tumors"; it was supported by nonprofit RakFond (Cancer Fund)...

Ultrasound solves an important clinical problem in diagnosing arrhythmia

Columbia Engineers used their electromechanical wave imaging technique to localize cardiac arrhythmias more accurately than 12-lead electrocardiograms alone, while providing 3D visualization for easier anatomical location of the arrhythmia source Credit: Ultrasound Elasticity Imaging Laboratory/Columbia...

Using Nanopore Sequencing to Study Full-Length Transcripts and Splicing Isoforms

Sponsored content brought to you by Chronic Lymphocytic Leukemia (CLL) is the most common form of blood cancer in adults, with an estimated incidence of up to 5.5 per 100,000 people worldwide. Alison Tang, a...

DBV Technologies’ Peanut Allergy Treatment Hits FDA Setback

French biotech DBV Technologies’ bid for the US approval of a skin patch to treat nut allergies could be delayed as the FDA requested more information on the patch’s efficacy. Specifically, the FDA requested more...

Vir Biotechnology reports early progress in antibody treatment for Covid-19 – STAT

Vir Biotechnology, a San Francisco-based biotechnology firm, said Wednesday that laboratory testing showed two of its antibody drugs appeared to neutralize the coronavirus that causes Covid-19 and that it would pursue testing them in...

Vir Biotechnology Proceeding with Two Clinical Development Candidates for COVID-19 – BioSpace

- Multiple antibodies identified that neutralize SARS-CoV-2- Phase 1/2 clinical testing planned for this summer SAN FRANCISCO, March 25, 2020 (GLOBE NEWSWIRE) --Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that it has identified multiple human monoclonal...